{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:05:30Z","timestamp":1791443130228,"version":"4.3.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011272","name":"EC | EC Seventh Framework Programm | FP7 Health","doi-asserted-by":"publisher","award":["602102"],"award-info":[{"award-number":["602102"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41434-025-00566-1","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:54:31Z","timestamp":1759046071000},"page":"581-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications"],"prefix":"10.1038","volume":"32","author":[{"given":"Stefano","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-105X","authenticated-orcid":false,"given":"Barbara","family":"Bettegazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-5942","authenticated-orcid":false,"given":"Selene","family":"Ingusci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Verlengia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5731-5490","authenticated-orcid":false,"given":"Anna Sofia","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Codazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-2645","authenticated-orcid":false,"given":"Joseph C.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Simonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fncel.2019.00046","volume":"13","author":"LF Duarte","year":"2019","unstructured":"Duarte LF, Far\u00edas MA, \u00c1lvarez DM, Bueno SM, Riedel CA, Gonz\u00e1lez PA. Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders. Front Cell Neurosci. 2019;13:46.","journal-title":"Front Cell Neurosci"},{"key":"566_CR2","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence. 2021;12:2670\u2013702.","journal-title":"Virulence"},{"key":"566_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0161-6420(01)00556-5","volume":"108","author":"RN Van Gelder","year":"2001","unstructured":"Van Gelder RN, Willig JL, Holland GN, Kaplan HJ. Herpes simplex virus type 2 as a cause of acute retinal necrosis syndrome in young patients. Ophthalmology. 2001;108:869\u201376.","journal-title":"Ophthalmology"},{"key":"566_CR4","doi-asserted-by":"publisher","unstructured":"Chauhan P, Begum MY, Narapureddy BR, Gupta S, Wadhwa K, Singh G et al. Unveiling the involvement of Herpes simplex virus-1 in Alzheimer\u2019s disease: possible mechanisms and therapeutic implications. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04535-4. 2024.","DOI":"10.1007\/s12035-024-04535-4"},{"key":"566_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","volume":"33","author":"GA Jamieson","year":"1991","unstructured":"Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains. J Med Virol. 1991;33:224\u20137.","journal-title":"J Med Virol"},{"key":"566_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"RF Itzhaki","year":"1997","unstructured":"Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet. 1997;349:241\u20134.","journal-title":"Lancet"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","volume":"429","author":"MA Wozniak","year":"2007","unstructured":"Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular \u03b2-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429:95\u2013100.","journal-title":"Neurosci Lett"},{"key":"566_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115109","volume":"44","author":"VR Hyde","year":"2025","unstructured":"Hyde VR, Zhou C, Fernandez JR, Chatterjee K, Ramakrishna P, Lin A, et al. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease. Cell Rep. 2025;44:115109.","journal-title":"Cell Rep"},{"key":"566_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/jnr.23003","volume":"90","author":"G \u00c1lvarez","year":"2012","unstructured":"\u00c1lvarez G, Aldudo J, Alonso M, Santana S, Valdivieso F. Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res. 2012;90:1020\u20139.","journal-title":"J Neurosci Res"},{"key":"566_CR10","doi-asserted-by":"publisher","first-page":"2323.e13","DOI":"10.1016\/j.neurobiolaging.2010.06.009","volume":"32","author":"R Piacentini","year":"2011","unstructured":"Piacentini R, Civitelli L, Ripoli C, Marcocci ME, De Chiara G, Garaci E, et al. HSV-1 promotes Ca2+-mediated APP phosphorylation and A\u03b2 accumulation in rat cortical neurons. Neurobiol Aging. 2011;32:2323.e13\u20132323.e26.","journal-title":"Neurobiol Aging"},{"key":"566_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14548","volume":"30","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xu K, Shu F, Zhang F. Neurotropic virus infection and neurodegenerative diseases: Potential roles of autophagy pathway. CNS Neurosci Ther. 2024;30:e14548.","journal-title":"CNS Neurosci Ther"},{"key":"566_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0006-8993(85)91075-3","volume":"341","author":"ML Mayer","year":"1985","unstructured":"Mayer ML, James MH, Russell RJ, Kelly JS, Wise JCM, Pasternak CA. Spontaneous electrical activity induced by herpes virus infection in rat sensory neuron cultures. Brain Res. 1985;341:360\u20134.","journal-title":"Brain Res"},{"key":"566_CR13","doi-asserted-by":"crossref","unstructured":"Le Hars M, Joussain C, J\u00e9gu T, Epstein AL. Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy\u2014an update. Gene Ther. 2024:1\u201311.","DOI":"10.1038\/s41434-024-00500-x"},{"key":"566_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40291-023-00687-6","volume":"28","author":"B Bettegazzi","year":"2024","unstructured":"Bettegazzi B, Cattaneo S, Simonato M, Zucchini S, Soukupova M. Viral vector-based gene therapy for epilepsy: What does the future hold?. Mol Diagn Ther. 2024;28:5\u201313.","journal-title":"Mol Diagn Ther"},{"key":"566_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther. 2021;29:464\u201388.","journal-title":"Mol Ther"},{"key":"566_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41583-020-00382-z","volume":"21","author":"AR Nectow","year":"2020","unstructured":"Nectow AR, Nestler EJ. Viral tools for neuroscience. Nat Rev Neurosci. 2020;21:669\u201381.","journal-title":"Nat Rev Neurosci"},{"key":"566_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/diseases6030074","volume":"6","author":"S Artusi","year":"2018","unstructured":"Artusi S, Miyagawa Y, Goins W, Cohen J, Glorioso J. Herpes Simplex virus vectors for gene transfer to the central nervous system. Diseases. 2018;6:74.","journal-title":"Diseases"},{"key":"566_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtm.2022.06.007","volume":"26","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Miyagawa Y, Sukegawa M, Tomono T, Yamamoto M, Adachi K, et al. Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors. Mol Ther Methods Clin Dev. 2022;26:132\u201343.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"566_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s40265-023-01921-5","volume":"83","author":"S Dhillon","year":"2023","unstructured":"Dhillon S. Beremagene Geperpavec: first approval. Drugs. 2023;83:1131\u20135.","journal-title":"Drugs"},{"key":"566_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol. 2023;20:160\u201377.","journal-title":"Nat Rev Clin Oncol"},{"key":"566_CR21","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1128\/JVI.01633-10","volume":"84","author":"H Uchida","year":"2010","unstructured":"Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, et al. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of Herpes simplex virus type 1 infection. J Virol. 2010;84:12200\u20139.","journal-title":"J Virol"},{"key":"566_CR22","doi-asserted-by":"publisher","first-page":"E1632","DOI":"10.1073\/pnas.1423556112","volume":"112","author":"Y Miyagawa","year":"2015","unstructured":"Miyagawa Y, Marino P, Verlengia G, Uchida H, Goins WF, Yokota S, et al. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. Proc Natl Acad Sci USA. 2015;112:E1632\u2013E1641.","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01635-1","volume":"7","author":"G Verlengia","year":"2017","unstructured":"Verlengia G, Miyagawa Y, Ingusci S, Cohen JB, Simonato M, Glorioso JC. Engineered HSV vector achieves safe long-term transgene expression in the central nervous system. Sci Rep. 2017;7:1507.","journal-title":"Sci Rep"},{"key":"566_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.omtm.2020.03.014","volume":"17","author":"S Kuroda","year":"2020","unstructured":"Kuroda S, Miyagawa Y, Sato Y, Yamamoto M, Adachi K, Kinoh H, et al. Protocol optimization for the production of the non-cytotoxic J\u0394NI5 HSV vector deficient in expression of immediately early genes. Mol Ther Methods Clin Dev. 2020;17:612\u201321.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"566_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04062-3","volume":"12","author":"B Bettegazzi","year":"2021","unstructured":"Bettegazzi B, Sebastian Monasor L, Bellani S, Codazzi F, Restelli LM, Colombo AV, et al. Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer\u2019s disease. Cell Death Dis. 2021;12:1\u201314.","journal-title":"Cell Death Dis"},{"key":"566_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.862325","volume":"16","author":"C Rosato","year":"2022","unstructured":"Rosato C, Bettegazzi B, Intagliata P, Balbontin Arenas M, Zacchetti D, Lanati A, et al. Redox and calcium alterations of a m\u00fcller cell line exposed to diabetic retinopathy-like environment. Front Cell Neurosci. 2022;16:862325.","journal-title":"Front Cell Neurosci"},{"key":"566_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1647-5","volume":"16","author":"N Hensel","year":"2019","unstructured":"Hensel N, Raker V, F\u00f6rthmann B, Detering NT, Kubinski S, Buch A, et al. HSV-1 triggers paracrine fibroblast growth factor response from cortical brain cells via immediate-early protein ICP0. J Neuroinflammation. 2019;16:248.","journal-title":"J Neuroinflammation"},{"key":"566_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1534\/genetics.104.040410","volume":"170","author":"JW Drake","year":"2005","unstructured":"Drake JW, Hwang CBC. On the mutation rate of Herpes simplex virus type 1. Genetics. 2005;170:969\u201370.","journal-title":"Genetics"},{"key":"566_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.virol.2008.03.018","volume":"376","author":"MA Murphy","year":"2008","unstructured":"Murphy MA, Bucks MA, O\u2019Regan KJ, Courtney RJ. The HSV-1 tegument protein pUL46 associates with cellular membranes and viral capsids. Virology. 2008;376:279\u201389.","journal-title":"Virology"},{"key":"566_CR30","doi-asserted-by":"publisher","unstructured":"You H, Zheng S, Huang Z, Lin Y, Shen Q, Zheng C Herpes Simplex Virus 1 Tegument Protein UL46 Inhibits TANK-Binding Kinase 1-Mediated Signaling. mBio 2019;10: https:\/\/doi.org\/10.1128\/mbio.00919-19.","DOI":"10.1128\/mbio.00919-19"},{"key":"566_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1128\/JVI.75.2.821-833.2001","volume":"75","author":"DC Johnson","year":"2001","unstructured":"Johnson DC, Webb M, Wisner TW, Brunetti C. Herpes simplex virus gE\/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol. 2001;75:821\u201333.","journal-title":"J Virol"},{"key":"566_CR32","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1099\/0022-1317-78-11-2923","volume":"78","author":"Y Nishiyama","year":"1997","unstructured":"Nishiyama Y, Yamada H, Yamashita Y, Daikoku T, Tsurumi T, Jiang YM. The product of the US10 gene of herpes simplex virus type 1 is a capsid\/tegument-associated phosphoprotein which copurifies with the nuclear matrix. J Gen Virol. 1997;78:2923\u201331.","journal-title":"J Gen Virol"},{"key":"566_CR33","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1073\/pnas.0608374104","volume":"104","author":"RP Subramanian","year":"2007","unstructured":"Subramanian RP, Geraghty RJ. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc Natl Acad Sci USA. 2007;104:2903\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR34","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1128\/JVI.01456-16","volume":"90","author":"Y Okubo","year":"2016","unstructured":"Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H, et al. Syncytial mutations do not impair the specificity of entry and spread of a glycoprotein D receptor-retargeted herpes simplex virus. J Virol. 2016;90:11096\u2013105.","journal-title":"J Virol"},{"key":"566_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2217\/fvl.14.100","volume":"10","author":"AE Ambrosini","year":"2015","unstructured":"Ambrosini AE, Enquist LW. Cell-fusion events induced by \u03b1-herpesviruses. Future Virol. 2015;10:185\u2013200.","journal-title":"Future Virol"},{"key":"566_CR36","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1128\/JVI.00104-12","volume":"86","author":"SA Connolly","year":"2012","unstructured":"Connolly SA, Longnecker R. Residues within the C-terminal arm of the herpes simplex virus 1 glycoprotein B ectodomain contribute to its refolding during the fusion step of virus entry. J Virol. 2012;86:6386\u201393.","journal-title":"J Virol"},{"key":"566_CR37","doi-asserted-by":"publisher","first-page":"e1000640","DOI":"10.1371\/journal.ppat.1000640","volume":"5","author":"KM McCarthy","year":"2009","unstructured":"McCarthy KM, Tank DW, Enquist LW. Pseudorabies virus infection alters neuronal activity and connectivity in vitro. PLoS Pathog. 2009;5:e1000640.","journal-title":"PLoS Pathog"},{"key":"566_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1113\/jphysiol.1986.sp016119","volume":"375","author":"ML Mayer","year":"1986","unstructured":"Mayer ML. Selective block of inward but not outward rectification in rat sensory neurones infected with herpes simplex virus. J Physiol. 1986;375:327\u201338.","journal-title":"J Physiol"},{"key":"566_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s13365-017-0545-9","volume":"23","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Hsia S-C, Martin-Caraballo M. Regulation of T-type Ca2+ channel expression by herpes simplex virus-1 infection in sensory-like ND7 cells. J Neurovirol. 2017;23:657\u201370.","journal-title":"J Neurovirol"},{"key":"566_CR40","doi-asserted-by":"crossref","unstructured":"Koyuncu OO, Enquist LW, Engel EA. Invasion of the nervous system. Current Issues Mol Biol. 2021:1\u201362.","DOI":"10.21775\/cimb.041.001"},{"key":"566_CR41","doi-asserted-by":"publisher","unstructured":"Fan Q, Longnecker R, Connolly SA. Herpes simplex virus glycoprotein B mutations define structural sites in domain I, the membrane proximal region, and the cytodomain that regulate entry. J Virol. 2021;95: https:\/\/doi.org\/10.1128\/jvi.01050-21.","DOI":"10.1128\/jvi.01050-21"},{"key":"566_CR42","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","volume":"39","author":"A Snowball","year":"2019","unstructured":"Snowball A, Chabrol E, Wykes RC, Shekh-Ahmad T, Cornford JH, Lieb A, et al. Epilepsy gene therapy using an engineered potassium channel. J Neurosci. 2019;39:3159\u201369.","journal-title":"J Neurosci"},{"key":"566_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnmol.2020.603409","volume":"13","author":"JA Szczygie\u0142","year":"2020","unstructured":"Szczygie\u0142 JA, Danielsen KI, Melin E, Rosenkranz SH, Pankratova S, Ericsson A, et al. Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in Rats. Front Mol Neurosci. 2020;13:232.","journal-title":"Front Mol Neurosci"},{"key":"566_CR44","doi-asserted-by":"crossref","unstructured":"Jensen TL, G\u00f8tzsche CR, Woldbye DPD. Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord. Front Mol Neurosci. 2021;14. https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2021.695937 (accessed 14 Jan2022).","DOI":"10.3389\/fnmol.2021.695937"},{"key":"566_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42466-021-00162-9","volume":"4","author":"S Jablonka","year":"2022","unstructured":"Jablonka S, Hennlein L, Sendtner M. Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders. Neurol Res Pr. 2022;4:2.","journal-title":"Neurol Res Pr"},{"key":"566_CR46","doi-asserted-by":"crossref","unstructured":"Terzic B, Melin E, Fagergren P, Dobry D, Cattaneo S, Giupponi I, et al. AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus. Mol Therapy. 2025;33:4239\u201358.","DOI":"10.1016\/j.ymthe.2025.06.019"},{"key":"566_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","volume":"28","author":"G Colasante","year":"2020","unstructured":"Colasante G, Lignani G, Brusco S, Berardino CD, Carpenter J, Giannelli S, et al. dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice. Mol Ther. 2020;28:235\u201353.","journal-title":"Mol Ther"},{"key":"566_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.632522","volume":"15","author":"P Lubroth","year":"2021","unstructured":"Lubroth P, Colasante G, Lignani G. In vivo genome editing therapeutic approaches for neurological disorders: Where are we in the translational pipeline?. Front Neurosci. 2021;15:632522.","journal-title":"Front Neurosci"},{"key":"566_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1535759718822846","volume":"19","author":"S Ingusci","year":"2019","unstructured":"Ingusci S, Cattaneo S, Verlengia G, Zucchini S, Simonato M. A matter of genes: the hurdles of gene therapy for epilepsy. Epilepsy Curr. 2019;19:38\u201343.","journal-title":"Epilepsy Curr"},{"key":"566_CR50","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","volume":"81","author":"X Xu","year":"2021","unstructured":"Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol Cell. 2021;81:4333\u20134345.e4.","journal-title":"Mol Cell"},{"key":"566_CR51","doi-asserted-by":"publisher","unstructured":"Tornabene P, Trapani I, Minopoli R, Centrulo M, Lupo M, Simone S, et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aav4523.","DOI":"10.1126\/scitranslmed.aav4523"},{"key":"566_CR52","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fphar.2019.00724","volume":"10","author":"S Ingusci","year":"2019","unstructured":"Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M. Gene therapy tools for brain diseases. Front Pharmacol. 2019;10:724.","journal-title":"Front Pharmacol"},{"key":"566_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.omtm.2021.03.020","volume":"21","author":"M Soukupov\u00e1","year":"2021","unstructured":"Soukupov\u00e1 M, Zucchini S, Trempat P, Ingusci S, Perrier-Biollay C, Barbieri M, et al. Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells. Mol Ther Methods Clin Dev. 2021;21:399\u2013412.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"566_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omtm.2017.06.001","volume":"6","author":"Y Miyagawa","year":"2017","unstructured":"Miyagawa Y, Verlengia G, Reinhart B, Han F, Uchida H, Zucchini S, et al. Deletion of the virion host shut-off gene enhances neuronal-selective transgene expression from an HSV vector lacking functional IE genes. Mol Ther - Methods Clin Dev. 2017;6:79\u201390.","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"566_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-53168-7_2","volume":"223","author":"DJ Weed","year":"2017","unstructured":"Weed DJ, Nicola AV. Herpes simplex virus membrane fusion. Adv Anat Embryol Cell Biol. 2017;223:29\u201347.","journal-title":"Adv Anat Embryol Cell Biol"}],"updated-by":[{"DOI":"10.1038\/s41434-026-00615-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000}}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00566-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00566-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00566-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:02:34Z","timestamp":1776754954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00566-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00566-1","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the original version of this article, the given and family names of Anna Sofia Tascini and Silvia Zucchini were incorrectly structured. The name was displayed correctly in all versions at the time of publication.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41434-026-00615-3","URL":"https:\/\/doi.org\/10.1038\/s41434-026-00615-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C.G. is founder and CSO of Adolore Biotherapeutics, Inc., Senior Advisor of Replay Bio, and consultant of EG247. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. This work was supported by a grant from the European Community (FP7- HEALTH Project 602102 [EPITARGET]).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Animal Care and Use Committee of the San Raffaele Scientific Institute approved the animal use procedures. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}